Society for Immunotherapy of Cancer (SITC) 2026
Phoenix, Arizona
November 4, 2026 – November 8, 2026
SciLeads at SITC 2026
We’re excited to announce that SciLeads will be attending the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting.
As the premier global gathering for the cancer immunotherapy field, this event is a crucial touchpoint for our team to connect with the researchers, clinicians, and industry innovators driving the next generation of immuno-oncology breakthroughs.
SITC 2026 brings together an international community of leaders from academia, government, and the private sector to share cutting-edge science and foster collaboration. Whether you are focused on basic research, clinical trials, or the development of novel cancer therapeutics, this conference offers unparalleled opportunities to engage with the field’s most influential voices. We look forward to seeing you in Phoenix to discuss how we can help accelerate your research and commercial goals.
About SITC 2026
The SITC Annual Meeting is the world’s leading conference dedicated to advancing the science and application of cancer immunotherapy. The 2026 agenda is packed with five days of high-level scientific exchange, covering everything from T cell recognition mechanisms to the clinical application of personalized cancer vaccines. The conference provides a truly multidisciplinary environment, where attendees can explore the latest data in tumor immunology, network with key opinion leaders, and participate in interactive educational sessions designed to improve patient outcomes. From oral abstract presentations and poster sessions to industry-sponsored symposia, SITC 2026 is where the standard of care is being redefined.
Key Details for SITC 2026
- Location: Phoenix Convention Center, Phoenix, Arizona
- Dates: November 4–8, 2026
- Event Program: View the full SITC 2026 Program
Quick Links for SITC 2026
Deadlines for SITC 2026
- August 07, 2026: Regular and Early Career Investigator Award abstract presentation confirmations due
- August 24, 2026: Early registration discount deadline
- October 02, 2026: Abstract titles and authors released
- October 07, 2026: Housing reservation deadline
- November 03, 2026: Embargo lifted and full abstracts made public
Key Topics and Speakers for SITC 2026
Keynote Speakers:
- Ton Schumacher, PhD (Netherlands Cancer Institute): Keynote Lecture: “T Cell Recognition of Human Cancer: Cracking the Code”
- Catherine J. Wu, MD (Dana-Farber Cancer Institute): Richard V. Smalley Memorial Award & Lectureship: “Getting Off the Rollercoaster: Personalized Cancer Vaccines Come of Age”
Main Focus Areas:
- Advancements in T cell response measurement and manipulation
- Personalized tumor vaccines in melanoma and glioblastoma
- Genomics-based approaches for immunogenic antigen discovery
- Clinical trial design and resistance mechanisms in immuno-oncology
- Basic and applied research in tumor microenvironments
Who attends SITC 2026
- Academic and Clinical Researchers
- Oncologists and Clinicians
- Biotechnology and Pharmaceutical Industry Professionals
- Early Career Scientists and Postdoctoral Fellows
- Undergraduate and Graduate Students in STEM
- Regulatory and Government Agency Representatives
- Medical Device and Scientific Supply Manufacturers
- Informatics and Data Management Specialists
“SciLeads has been critical to the success of our sales and marketing efforts. I don't know where we would be without its data and insights.”
